What Are the Consequences of the COVID-19 Pandemic on Interventional Cardiology Programs? Can Fibrinolysis be Considered an Option for Stable STEMI Patients with Active COVID-19? Should Stable NSTEMI Patients Initially Be Treated with Drug Therapy?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

What Are the Consequences of the COVID-19 Pandemic on Interventional Cardiology Programs? Can Fibrinolysis be Considered an Option for Stable STEMI Patients with Active COVID-19? Should Stable NSTEMI Patients Initially Be Treated with Drug Therapy?

By Rush University Medical Center FEATURING Clifford Kavinsky

54 views

June 5, 2020

1 Comment

Post-Pandemic Orthopedic Care: Challenges & Opportunities

Feat. J. Warner

05:17

American College of Cardiology

How Is the Mount Sinai Health System Combating COVID-19 in New York …

Feat. S. Pinney

04:32

Stanford Medicine

DEA Guidelines for Prescribing During COVID-19: How Do You Continue …

Feat. S. Pritzlaff

01:10

Philips

How have OBLs and ASCs helped during the COVID crisis? [Dr. Craig Wa…

Feat. C. Walker

Philips

How have OBLs and ASCs Helped During the COVID Crisis? [David Konur,…

Feat. D. Konur

13:03

Stanford Medicine

COVID-19 Pain Management Best Practices: How to Prioritize Procedure…

Feat. S. Pritzlaff, M. Leong, R. Prasad

24:48

Stanford Medicine

Acute & Long-Term Cardiac Effects of COVID-19

Feat. E. Profita

15:43

Northwestern Medicine Cardiovascular Care

COVID-19 and Venous Thromboembolism: What Role Do Clotting and Antic…

Feat. M. Cuttica

11:07

Northwestern Medicine Cardiovascular Care

What Are the Considerations for Management of ST-Elevation Myocardia…

Feat. R. Bach

05:11

American College of Cardiology

COVID Crisis: STS/ACC TVT Registry: What Is the Sensitivity and Spec…

Feat. J. Michaels, V. Thourani, N. Fishman

10:30

Houston Methodist DeBakey Heart and Vascular Center

COVID-19: What Can We Learn from Surgeons in China on How to Manage …

Feat. B. Starnes, D. McDevitt, K. Slaw, R. Dalman, A. Lumsden, T. Forbes, D. Schneider, K. Hodgson

16:00

24th Annual Heart Failure 2020: an Update on Therapy

COVID-19 and Heart Failure

Feat. M. Mehra

06:49

Mount Sinai

COVID-19: What Types of Thrombosis Are Commonly Seen? Are Anticoagul…

Feat. J. Olin

22:46

Houston Methodist DeBakey Heart and Vascular Center

COVID-19 and Heart Failure: How to Evaluate Patients? Can You Give B…

Feat. N. Fida

22:19

UCLA Health

What We Learned from COVID-19

Feat. O. Emeruwa

21:42

UAB Hematology Review 2021

Hematologic Manifestations of COVID-19: Thrombosis Mechanisms and Ri…

Feat. R. Gangaraju

18:12

Keck School of Medicine of USC

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …

Feat. L. Clavijo

31:27

Sarju Ganatra

COVID-19 Treatment Considerations in Cardio-Oncology

67:29

Philips

PAD and CLI State of the Art: What Is the Role of Telemedicine? How …

Feat. C. Lesar, C. Walker, S. Madassery, T. Yates

10:06

Cardiometabolic Health Congress (CMHC)

COVID-19: Should ACE inhibitors and Angiotensin Receptor Blockers Be…

Feat. K. Ferdinand

Login

Login

Join VuMedi

What Are the Consequences of the COVID-19 Pandemic on Interventional Cardiology Programs? Can Fibrinolysis be Considered an Option for Stable STEMI Patients with Active COVID-19? Should Stable NSTEMI Patients Initially Be Treated with Drug Therapy?

Related Content